Literature DB >> 1703370

Effects of specific monoclonal antibodies on La Crosse virus neutralization: aggregation, inactivation by Fab fragments, and inhibition of attachment to baby hamster kidney cells.

L Kingsford1, K H Boucquey, T P Cardoso.   

Abstract

At high concentrations, several monoclonal antibodies to the G1 glycoprotein of La Crosse (LAC) virus aggregated the virus. To determine whether this accounted for the neutralization, the monoclonal antibodies were digested to make Fab fragments. With one exception, each monovalent antibody neutralized LAC virus to the same extent that bivalent antibody did, although higher concentrations were needed. Fab fragments of synergistic pairs of antibodies also exhibited enhanced binding in a competition binding assay but did not increase neutralization. To determine specific mechanisms for neutralization, the effects of polyclonal or monoclonal antibodies on virus attachment were examined. Polyclonal antibody to LAC virus reduced virus attachment by only 68% although it neutralized 99.99% of the virus. When virus was preincubated with a neutralizing monoclonal antibody to each of seven antigenic regions on G1, only antibody to one region reduced attachment of virus by as much as 92%. Antibodies to two regions that neutralize virus by 90-98% only inhibited attachment by 9 and 13%, respectively. The other antibodies showed intermediate degrees of neutralization and inhibition of attachment. Pairs of antibodies previously shown to be synergistic in neutralizing activity did not inhibit attachment any more than the single antibodies did.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 1703370     DOI: 10.1016/0042-6822(91)90073-k

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  2 in total

1.  Cellular localization and antigenic characterization of crimean-congo hemorrhagic fever virus glycoproteins.

Authors:  Andrea Bertolotti-Ciarlet; Jonathan Smith; Karin Strecker; Jason Paragas; Louis A Altamura; Jeanne M McFalls; Natalia Frias-Stäheli; Adolfo García-Sastre; Connie S Schmaljohn; Robert W Doms
Journal:  J Virol       Date:  2005-05       Impact factor: 5.103

2.  A recombinant human Fab expressed in Escherichia coli neutralizes rabies virus.

Authors:  S C Cheung; B Dietzschold; H Koprowski; A L Notkins; R F Rando
Journal:  J Virol       Date:  1992-11       Impact factor: 5.103

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.